Sanofi

XNAS

Last traded price · USD

$47.13

−0.72%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:43 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $47.47
Volume: 18,441
Day's high: —
Day's low: —

In brief

Sanofi is a US-listed company listed on Nasdaq, valued at about $112.93B.
Its shares closed at $47.47 on 4 Nov 2026, down 3.3% over the past year.
From India you can buy SNY in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Sanofi (SNY) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole SNY share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade SNY options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Above its 50- and 200-day averages
The 4 Nov 2026 close of $47.47 was 12.4% above its 50-day average ($42.22) and 7.1% above its 200-day average ($44.32). It has closed above the 200-day for 4 sessions, since 30 Oct 2026. The 50-day average crossed below the 200-day on 28 May 2025, 362 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Rose 4.7% on 4 Nov 2026
The 4 Nov 2026 gain of 4.7% was 4.1× its average daily move of 1.1% over the past year, and its largest one-day gain since 4 Jun 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
Behind SPY over 1 year
1 month: +20.0% (SPY −1.6%). 3 months: +11.0% (SPY −0.4%). 1 year: −3.3% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SNY, SPY · as of 4 Nov 2026
Volume 4.4× its 30-session average on 30 Oct 2026
30 Oct 2026 volume of 15.1M shares was 4.4× the average of the 30 sessions before it (3.4M), as the price rose 2.8%. SPY traded 1.9× its own average that session.
Daily volume against a 30-session baseline · as of 30 Oct 2026
RSI(14) at 77.3, 70 or above
The 14-session relative strength index closed at 77.3 on 4 Nov 2026, its 3rd session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+20.0%

6 months+8.5%

1 year−3.3%

5 years−8.3%

Newswire

About

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Website

Notable moves

September 4, 2025
−9.14%
October 27, 2023
−19.13%
December 6, 2022
+8.06%

Sanofi

XNAS

Last traded price · USD

$47.13

−0.72%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:43 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $47.47
Volume: 18,441
Day's high: —
Day's low: —

In brief

Sanofi is a US-listed company listed on Nasdaq, valued at about $112.93B.
Its shares closed at $47.47 on 4 Nov 2026, down 3.3% over the past year.
From India you can buy SNY in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Sanofi (SNY) shares from India?

Do I need the price of a whole SNY share to invest?

How much can I invest in US stocks in a year?

Can I trade SNY options or futures?

Insights

Quotes run fifteen minutes behind.

Above its 50- and 200-day averages
The 4 Nov 2026 close of $47.47 was 12.4% above its 50-day average ($42.22) and 7.1% above its 200-day average ($44.32). It has closed above the 200-day for 4 sessions, since 30 Oct 2026. The 50-day average crossed below the 200-day on 28 May 2025, 362 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Rose 4.7% on 4 Nov 2026
The 4 Nov 2026 gain of 4.7% was 4.1× its average daily move of 1.1% over the past year, and its largest one-day gain since 4 Jun 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
Behind SPY over 1 year
1 month: +20.0% (SPY −1.6%). 3 months: +11.0% (SPY −0.4%). 1 year: −3.3% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SNY, SPY · as of 4 Nov 2026
Volume 4.4× its 30-session average on 30 Oct 2026
30 Oct 2026 volume of 15.1M shares was 4.4× the average of the 30 sessions before it (3.4M), as the price rose 2.8%. SPY traded 1.9× its own average that session.
Daily volume against a 30-session baseline · as of 30 Oct 2026
RSI(14) at 77.3, 70 or above
The 14-session relative strength index closed at 77.3 on 4 Nov 2026, its 3rd session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+20.0%

6 months+8.5%

1 year−3.3%

5 years−8.3%

Newswire

About

Website

Notable moves

September 4, 2025
−9.14%
October 27, 2023
−19.13%
December 6, 2022
+8.06%

Sanofi

Sanofi in brief

Above its 50- and 200-day averages

Rose 4.7% on 4 Nov 2026

Behind SPY over 1 year

Volume 4.4× its 30-session average on 30 Oct 2026

RSI(14) at 77.3, 70 or above

Sanofi

Sanofi in brief

Above its 50- and 200-day averages

Rose 4.7% on 4 Nov 2026

Behind SPY over 1 year

Volume 4.4× its 30-session average on 30 Oct 2026

RSI(14) at 77.3, 70 or above